SlideShare ist ein Scribd-Unternehmen logo
1 von 19
Downloaden Sie, um offline zu lesen
La Participación en redes
Ejemplo de la EIP AHA
Anaïs Le Corvec
Unitat de Projectes de Recerca - Vall d’Hebron Institut de Recerca
24 de Octubre 2013
Que es la EIP AHA?
Porque participar?
Que ventajas, y pasos a
seguir?
Active and	Healthy
Ageing
A European Innovation Partnership
OBJECTIVES
-addressing societal challenges and, in so doing,
-enhancing Europe's competitiveness, against the background of
globalisation and current fiscal constraints.
The concept provides for a strategic approach to innovation which
has its origins in the Europe 2020 strategy.
In addressing the challenge of ageing, the European Commission
aims to increase by two years the average number of healthy life
years (HLYs) in the European Union by 2020 :
• improving the health status and quality of life of European
citizens, with a particular focus on older people;
• supporting the long-term sustainability and efficiency of health
and social care systems; and
• enhancing the competitiveness of EU industry through an
improved business environment providing the foundations for
growth
LOS GRUPOS DE TRABAJO

1. Prescription and adherence action at the regional level.
2. Personal health management, starting with a falls prevention
initiative.
3. Action for prevention of functional decline and frailty.
4. Replicating and tutoring integrated care for chronic diseases, including
remote monitoring at regional level
5. Development of interoperable independent living solutions, including
guidelines for business models
European Innovation Partnership on Active and Healthy
Ageing

B3: Integrated Care Action Group
Why engage in the EIP-AHA?
Learn from the others’ good practice
Combine evidence
Collaboration leading to efficiency in (re-)design and validation of
innovative care services
Efficiency of design leading to expansion of services to larger
population - with the same level of investment
Being stronger in application for funding at local/national level
Local industry seeing a larger market, beyond the “local border”
Political support
Challenges to care delivery models
Ageing
society
Health
workforce
shortage
Chronic
conditions
Financial
unsustainability
HLY vs LE
Health
inequalities
Action Plan

Ado
p
6 No ted:
vem
ber
201
2
Our activity areas
Organisational Models
Change Management
Workforce Development, Education and
Training
Risk Stratification
Care Pathways
Patient Empowerment 
Electronic Care Records / ICT/Teleservices
Finance, Funding and Procurement
Communication and Dissemination

mapping, repositories of good practices, toolkits
Care pathways – an example
Aligning existing
funded activities

Mapping best practice
implementation in the EU
regions
Evidence base for integrated care pathways
and associated guidelines and processes

A repository of implemented chronic care pathways,
integrated care pathways for chronic conditions

Toolkit for Integrated Care Pathways:
Care pathway redesign & implementation plans & replication
European standardised methodologies & indicators
Standardised protocols, procedures and activity workflows
B3 Good Practices
• Objective: to gather an initial map of
current integrated care activities relating
to the B3 Action Areas
• Who: All B3 members were invited to
complete the B3 Good Practice template
• When: March-September 2013
Collection of good practices

• 85 good practices
• 23 regions
• 8 action areas
… and the collection
is still on-going
Contributing Regions and Countries*

*Size corresponding to number of good practices
Themes

•
•
•
•
•
•

50% of the good practices target one or more chronic disease (cardiovascular diseases,
COPD, diabetes, etc)
Numerous examples of comprehensive regional programmes for chronicity
Wide range of issues , incl. insurance, social security, housing, independent living,
volunteering, impact on competitiveness
Innovation in technologies, delivery of services and organisation
Patient-centered
Strong focus on implementation
Examples
Puglia, Italy:

Telecardiology programme to support patients affected by
cardiovascular diseases both in case of acute events and management of
chronic conditions.
•- Over 550.000 ECG performed,
•- significant reduction of avoidable death,
•- 60% underwent appropriate treatment and no hospitalization unless urgent
(only 11%)

Basque country:

Chronicity strategy
Risk stratification of patients
- the entire population (2.2mio) included
- 100% of health professionals know what care approach the patient
need in relation to their risks
- 11,000 hospital stay reduction & saving of €8.9mio (entire strategy)
Role of European Commission
Political advocacy
Support of scale-up, transferability and replication
Facilitating collaboration, communication, and partnerships
Monitoring & evaluation framework towards the EIP targets & goals
Improving framework conditions
Alignment of funding instruments
Development of a shared and robust evidence base
Enabling the exchange and transfer of good practices
EIP MEANS NO FUNDING BUT!

NETWORKING (THROUGH THE MARKET
PLACE)
POSSIBILITY TO INFLUENCE FUTURE
FUNDING PROGRAMMES
START NEW PROJECTS AND INITIATIVES IN
RESEARCH BUT ALSO CLOSE TO MARKET
GRACIAS POR SU ATENCIÓN!
EQUIPO PROYECTOS DE INVESTIGACIÓN
VALL D’HEBRON INSTITUTE OF RESEARCH
Cualquier duda: ugp@vhir.org

Weitere ähnliche Inhalte

Was ist angesagt?

Working together in health information for Health and Well-being in Europe
Working together in health information for Health and Well-being in EuropeWorking together in health information for Health and Well-being in Europe
Working together in health information for Health and Well-being in EuropeWHO Regional Office for Europe
 
Implications of Mobile Technology in Facilitating Integrated Care
Implications of Mobile Technology in Facilitating Integrated CareImplications of Mobile Technology in Facilitating Integrated Care
Implications of Mobile Technology in Facilitating Integrated Carehealthcareisi
 
Personalisation for Long Term Conditions in Cornwall
Personalisation for Long Term Conditions in CornwallPersonalisation for Long Term Conditions in Cornwall
Personalisation for Long Term Conditions in CornwallNHS Improving Quality
 
World health day 2018
World health day 2018World health day 2018
World health day 2018KEM Hospital
 
DELSA/GOV 3rd Health meeting - Sarah THOMSON
DELSA/GOV 3rd Health meeting - Sarah THOMSONDELSA/GOV 3rd Health meeting - Sarah THOMSON
DELSA/GOV 3rd Health meeting - Sarah THOMSONOECD Governance
 
Creating successful partnerships in yorkshire and humber
Creating successful partnerships in yorkshire and humberCreating successful partnerships in yorkshire and humber
Creating successful partnerships in yorkshire and humberPM Society
 
JA CHRODIS: Workshop on chronic disease mangement.
JA CHRODIS: Workshop on chronic disease mangement.JA CHRODIS: Workshop on chronic disease mangement.
JA CHRODIS: Workshop on chronic disease mangement.EU_CHRODIS
 
Russell Kennedy Not-for-profit Seminar: Strategic challenges facing primary ...
Russell Kennedy Not-for-profit Seminar: Strategic challenges facing primary ...Russell Kennedy Not-for-profit Seminar: Strategic challenges facing primary ...
Russell Kennedy Not-for-profit Seminar: Strategic challenges facing primary ...Russell_Kennedy
 
Primary Health Care. A key concern in a changing socio-economic environment.
Primary Health Care. A key concern in a changing socio-economic environment.Primary Health Care. A key concern in a changing socio-economic environment.
Primary Health Care. A key concern in a changing socio-economic environment.Evangelos Fragkoulis
 
GSPOA World Health Summit Workshop, Usman
GSPOA World Health Summit Workshop, UsmanGSPOA World Health Summit Workshop, Usman
GSPOA World Health Summit Workshop, UsmanUsman Mushtaq
 
DELSA/GOV 3rd Health meeting - Mark BLECHER
DELSA/GOV 3rd Health meeting - Mark BLECHERDELSA/GOV 3rd Health meeting - Mark BLECHER
DELSA/GOV 3rd Health meeting - Mark BLECHEROECD Governance
 
Mobilizing Knowledge to Improve Health and Social Care - Approaches and Chall...
Mobilizing Knowledge to Improve Health and Social Care - Approaches and Chall...Mobilizing Knowledge to Improve Health and Social Care - Approaches and Chall...
Mobilizing Knowledge to Improve Health and Social Care - Approaches and Chall...Health and Care Research Wales
 
Mary Higgins – ‘The Situation on the Ground – The Opportunities and Challenges
Mary Higgins – ‘The Situation on the Ground – The Opportunities and ChallengesMary Higgins – ‘The Situation on the Ground – The Opportunities and Challenges
Mary Higgins – ‘The Situation on the Ground – The Opportunities and ChallengesCiaran Holahan
 
QSIR knowledge exchange - Steve Fairman presentation
QSIR knowledge exchange   - Steve Fairman presentationQSIR knowledge exchange   - Steve Fairman presentation
QSIR knowledge exchange - Steve Fairman presentationNHS Improving Quality
 
Joining forces to overcome cancer by izaq odongo
Joining forces to overcome cancer by izaq odongoJoining forces to overcome cancer by izaq odongo
Joining forces to overcome cancer by izaq odongoKesho Conference
 
Carolyn Wallace CNRS presentation Sep 2013
Carolyn Wallace CNRS presentation Sep 2013Carolyn Wallace CNRS presentation Sep 2013
Carolyn Wallace CNRS presentation Sep 2013angewatkins
 
Scaling-up through Living Labs
Scaling-up through Living LabsScaling-up through Living Labs
Scaling-up through Living LabsAALForum
 

Was ist angesagt? (20)

Working together in health information for Health and Well-being in Europe
Working together in health information for Health and Well-being in EuropeWorking together in health information for Health and Well-being in Europe
Working together in health information for Health and Well-being in Europe
 
Implications of Mobile Technology in Facilitating Integrated Care
Implications of Mobile Technology in Facilitating Integrated CareImplications of Mobile Technology in Facilitating Integrated Care
Implications of Mobile Technology in Facilitating Integrated Care
 
Personalisation for Long Term Conditions in Cornwall
Personalisation for Long Term Conditions in CornwallPersonalisation for Long Term Conditions in Cornwall
Personalisation for Long Term Conditions in Cornwall
 
World health day 2018
World health day 2018World health day 2018
World health day 2018
 
DELSA/GOV 3rd Health meeting - Sarah THOMSON
DELSA/GOV 3rd Health meeting - Sarah THOMSONDELSA/GOV 3rd Health meeting - Sarah THOMSON
DELSA/GOV 3rd Health meeting - Sarah THOMSON
 
Creating successful partnerships in yorkshire and humber
Creating successful partnerships in yorkshire and humberCreating successful partnerships in yorkshire and humber
Creating successful partnerships in yorkshire and humber
 
JA CHRODIS: Workshop on chronic disease mangement.
JA CHRODIS: Workshop on chronic disease mangement.JA CHRODIS: Workshop on chronic disease mangement.
JA CHRODIS: Workshop on chronic disease mangement.
 
Russell Kennedy Not-for-profit Seminar: Strategic challenges facing primary ...
Russell Kennedy Not-for-profit Seminar: Strategic challenges facing primary ...Russell Kennedy Not-for-profit Seminar: Strategic challenges facing primary ...
Russell Kennedy Not-for-profit Seminar: Strategic challenges facing primary ...
 
Primary Health Care. A key concern in a changing socio-economic environment.
Primary Health Care. A key concern in a changing socio-economic environment.Primary Health Care. A key concern in a changing socio-economic environment.
Primary Health Care. A key concern in a changing socio-economic environment.
 
GSPOA World Health Summit Workshop, Usman
GSPOA World Health Summit Workshop, UsmanGSPOA World Health Summit Workshop, Usman
GSPOA World Health Summit Workshop, Usman
 
DELSA/GOV 3rd Health meeting - Mark BLECHER
DELSA/GOV 3rd Health meeting - Mark BLECHERDELSA/GOV 3rd Health meeting - Mark BLECHER
DELSA/GOV 3rd Health meeting - Mark BLECHER
 
Ev 20141028 c01_en
Ev 20141028 c01_enEv 20141028 c01_en
Ev 20141028 c01_en
 
Mobilizing Knowledge to Improve Health and Social Care - Approaches and Chall...
Mobilizing Knowledge to Improve Health and Social Care - Approaches and Chall...Mobilizing Knowledge to Improve Health and Social Care - Approaches and Chall...
Mobilizing Knowledge to Improve Health and Social Care - Approaches and Chall...
 
Mary Higgins – ‘The Situation on the Ground – The Opportunities and Challenges
Mary Higgins – ‘The Situation on the Ground – The Opportunities and ChallengesMary Higgins – ‘The Situation on the Ground – The Opportunities and Challenges
Mary Higgins – ‘The Situation on the Ground – The Opportunities and Challenges
 
QSIR knowledge exchange - Steve Fairman presentation
QSIR knowledge exchange   - Steve Fairman presentationQSIR knowledge exchange   - Steve Fairman presentation
QSIR knowledge exchange - Steve Fairman presentation
 
Joining forces to overcome cancer by izaq odongo
Joining forces to overcome cancer by izaq odongoJoining forces to overcome cancer by izaq odongo
Joining forces to overcome cancer by izaq odongo
 
Carolyn Wallace CNRS presentation Sep 2013
Carolyn Wallace CNRS presentation Sep 2013Carolyn Wallace CNRS presentation Sep 2013
Carolyn Wallace CNRS presentation Sep 2013
 
WHO Maximizing Positive Synergies: Academic Consortium
WHO Maximizing Positive Synergies: Academic ConsortiumWHO Maximizing Positive Synergies: Academic Consortium
WHO Maximizing Positive Synergies: Academic Consortium
 
Hugh Jones - Partnerships Between Universities, PSRBs and the NHS
Hugh Jones - Partnerships Between Universities, PSRBs and the NHSHugh Jones - Partnerships Between Universities, PSRBs and the NHS
Hugh Jones - Partnerships Between Universities, PSRBs and the NHS
 
Scaling-up through Living Labs
Scaling-up through Living LabsScaling-up through Living Labs
Scaling-up through Living Labs
 

Andere mochten auch

Using and combining the different tools for predicting the pathogenicity of s...
Using and combining the different tools for predicting the pathogenicity of s...Using and combining the different tools for predicting the pathogenicity of s...
Using and combining the different tools for predicting the pathogenicity of s...Vall d'Hebron Institute of Research (VHIR)
 
Dr. Esteban Domingo: Respuesta del virus de la hepatitis C a inhibidores. Inf...
Dr. Esteban Domingo: Respuesta del virus de la hepatitis C a inhibidores. Inf...Dr. Esteban Domingo: Respuesta del virus de la hepatitis C a inhibidores. Inf...
Dr. Esteban Domingo: Respuesta del virus de la hepatitis C a inhibidores. Inf...Vall d'Hebron Institute of Research (VHIR)
 
Allogeneicity and Immunogenicity of Stem Cell Therapy : a cardiovascular focus
Allogeneicity and Immunogenicity of Stem Cell Therapy : a cardiovascular focusAllogeneicity and Immunogenicity of Stem Cell Therapy : a cardiovascular focus
Allogeneicity and Immunogenicity of Stem Cell Therapy : a cardiovascular focusVall d'Hebron Institute of Research (VHIR)
 
Familial aggregation of bicuspid aortic valve: is it useful a family screeninng?
Familial aggregation of bicuspid aortic valve: is it useful a family screeninng?Familial aggregation of bicuspid aortic valve: is it useful a family screeninng?
Familial aggregation of bicuspid aortic valve: is it useful a family screeninng?Vall d'Hebron Institute of Research (VHIR)
 
Estudi de la funció del coactivador transcripcional PGC-1β en el teixit adipó...
Estudi de la funció del coactivador transcripcional PGC-1β en el teixit adipó...Estudi de la funció del coactivador transcripcional PGC-1β en el teixit adipó...
Estudi de la funció del coactivador transcripcional PGC-1β en el teixit adipó...Vall d'Hebron Institute of Research (VHIR)
 
"Enfermedades Minoritarias y Medicamentos huérfanos en la UE" by Dr. Josep To...
"Enfermedades Minoritarias y Medicamentos huérfanos en la UE" by Dr. Josep To..."Enfermedades Minoritarias y Medicamentos huérfanos en la UE" by Dr. Josep To...
"Enfermedades Minoritarias y Medicamentos huérfanos en la UE" by Dr. Josep To...Vall d'Hebron Institute of Research (VHIR)
 
NID1 and NUPR1 are ETV5 regulated genes involved in endometrial tumor dissemi...
NID1 and NUPR1 are ETV5 regulated genes involved in endometrial tumor dissemi...NID1 and NUPR1 are ETV5 regulated genes involved in endometrial tumor dissemi...
NID1 and NUPR1 are ETV5 regulated genes involved in endometrial tumor dissemi...Vall d'Hebron Institute of Research (VHIR)
 
The impact of SSC 2012 on the planning and evaluation of my hospital's perfor...
The impact of SSC 2012 on the planning and evaluation of my hospital's perfor...The impact of SSC 2012 on the planning and evaluation of my hospital's perfor...
The impact of SSC 2012 on the planning and evaluation of my hospital's perfor...Vall d'Hebron Institute of Research (VHIR)
 
Oxidative stress and atrial fibrillation: a long journey in to the clinic? (P...
Oxidative stress and atrial fibrillation: a long journey in to the clinic? (P...Oxidative stress and atrial fibrillation: a long journey in to the clinic? (P...
Oxidative stress and atrial fibrillation: a long journey in to the clinic? (P...Vall d'Hebron Institute of Research (VHIR)
 
Acute kidney injury in critically ill patients in the new millenium: definiti...
Acute kidney injury in critically ill patients in the new millenium: definiti...Acute kidney injury in critically ill patients in the new millenium: definiti...
Acute kidney injury in critically ill patients in the new millenium: definiti...Vall d'Hebron Institute of Research (VHIR)
 
Diagnóstico genético en enfermedades raras del metabolismo del hierro: Anemia...
Diagnóstico genético en enfermedades raras del metabolismo del hierro: Anemia...Diagnóstico genético en enfermedades raras del metabolismo del hierro: Anemia...
Diagnóstico genético en enfermedades raras del metabolismo del hierro: Anemia...Vall d'Hebron Institute of Research (VHIR)
 
"Rare diseases as platform to develop novel therapeutic strategies: the examp...
"Rare diseases as platform to develop novel therapeutic strategies: the examp..."Rare diseases as platform to develop novel therapeutic strategies: the examp...
"Rare diseases as platform to develop novel therapeutic strategies: the examp...Vall d'Hebron Institute of Research (VHIR)
 

Andere mochten auch (18)

Using and combining the different tools for predicting the pathogenicity of s...
Using and combining the different tools for predicting the pathogenicity of s...Using and combining the different tools for predicting the pathogenicity of s...
Using and combining the different tools for predicting the pathogenicity of s...
 
Multi-stage, multimodal Approaches for regenerative stroke therapies
Multi-stage, multimodal Approaches for regenerative stroke therapiesMulti-stage, multimodal Approaches for regenerative stroke therapies
Multi-stage, multimodal Approaches for regenerative stroke therapies
 
Gene Silencing using Polypurine Reverse Hoogsteen Hairpins
Gene Silencing using Polypurine Reverse Hoogsteen HairpinsGene Silencing using Polypurine Reverse Hoogsteen Hairpins
Gene Silencing using Polypurine Reverse Hoogsteen Hairpins
 
Dr. Esteban Domingo: Respuesta del virus de la hepatitis C a inhibidores. Inf...
Dr. Esteban Domingo: Respuesta del virus de la hepatitis C a inhibidores. Inf...Dr. Esteban Domingo: Respuesta del virus de la hepatitis C a inhibidores. Inf...
Dr. Esteban Domingo: Respuesta del virus de la hepatitis C a inhibidores. Inf...
 
Allogeneicity and Immunogenicity of Stem Cell Therapy : a cardiovascular focus
Allogeneicity and Immunogenicity of Stem Cell Therapy : a cardiovascular focusAllogeneicity and Immunogenicity of Stem Cell Therapy : a cardiovascular focus
Allogeneicity and Immunogenicity of Stem Cell Therapy : a cardiovascular focus
 
Familial aggregation of bicuspid aortic valve: is it useful a family screeninng?
Familial aggregation of bicuspid aortic valve: is it useful a family screeninng?Familial aggregation of bicuspid aortic valve: is it useful a family screeninng?
Familial aggregation of bicuspid aortic valve: is it useful a family screeninng?
 
Estudi de la funció del coactivador transcripcional PGC-1β en el teixit adipó...
Estudi de la funció del coactivador transcripcional PGC-1β en el teixit adipó...Estudi de la funció del coactivador transcripcional PGC-1β en el teixit adipó...
Estudi de la funció del coactivador transcripcional PGC-1β en el teixit adipó...
 
"Enfermedades Minoritarias y Medicamentos huérfanos en la UE" by Dr. Josep To...
"Enfermedades Minoritarias y Medicamentos huérfanos en la UE" by Dr. Josep To..."Enfermedades Minoritarias y Medicamentos huérfanos en la UE" by Dr. Josep To...
"Enfermedades Minoritarias y Medicamentos huérfanos en la UE" by Dr. Josep To...
 
NID1 and NUPR1 are ETV5 regulated genes involved in endometrial tumor dissemi...
NID1 and NUPR1 are ETV5 regulated genes involved in endometrial tumor dissemi...NID1 and NUPR1 are ETV5 regulated genes involved in endometrial tumor dissemi...
NID1 and NUPR1 are ETV5 regulated genes involved in endometrial tumor dissemi...
 
The impact of SSC 2012 on the planning and evaluation of my hospital's perfor...
The impact of SSC 2012 on the planning and evaluation of my hospital's perfor...The impact of SSC 2012 on the planning and evaluation of my hospital's perfor...
The impact of SSC 2012 on the planning and evaluation of my hospital's perfor...
 
IRDiRC: State of the Art. By Paul Lasko, PhD
IRDiRC: State of the Art. By Paul Lasko, PhDIRDiRC: State of the Art. By Paul Lasko, PhD
IRDiRC: State of the Art. By Paul Lasko, PhD
 
Oxidative stress and atrial fibrillation: a long journey in to the clinic? (P...
Oxidative stress and atrial fibrillation: a long journey in to the clinic? (P...Oxidative stress and atrial fibrillation: a long journey in to the clinic? (P...
Oxidative stress and atrial fibrillation: a long journey in to the clinic? (P...
 
Acute kidney injury in critically ill patients in the new millenium: definiti...
Acute kidney injury in critically ill patients in the new millenium: definiti...Acute kidney injury in critically ill patients in the new millenium: definiti...
Acute kidney injury in critically ill patients in the new millenium: definiti...
 
Diagnóstico genético en enfermedades raras del metabolismo del hierro: Anemia...
Diagnóstico genético en enfermedades raras del metabolismo del hierro: Anemia...Diagnóstico genético en enfermedades raras del metabolismo del hierro: Anemia...
Diagnóstico genético en enfermedades raras del metabolismo del hierro: Anemia...
 
"Rare diseases as platform to develop novel therapeutic strategies: the examp...
"Rare diseases as platform to develop novel therapeutic strategies: the examp..."Rare diseases as platform to develop novel therapeutic strategies: the examp...
"Rare diseases as platform to develop novel therapeutic strategies: the examp...
 
Nebulized antibiotics for treating Ventilator-Associated Pneumonia
Nebulized antibiotics for treating Ventilator-Associated PneumoniaNebulized antibiotics for treating Ventilator-Associated Pneumonia
Nebulized antibiotics for treating Ventilator-Associated Pneumonia
 
The Microcirculation in Sepsis
The Microcirculation in SepsisThe Microcirculation in Sepsis
The Microcirculation in Sepsis
 
"Biomarkers in sepsis and septic shock" by Prof. Jérôme Pugin
"Biomarkers in sepsis and septic shock" by Prof. Jérôme Pugin"Biomarkers in sepsis and septic shock" by Prof. Jérôme Pugin
"Biomarkers in sepsis and septic shock" by Prof. Jérôme Pugin
 

Ähnlich wie [Horizon 2020] La participación en las redes

Wojciech Dziworski EU #MWC14 #mHealth
Wojciech Dziworski EU #MWC14 #mHealthWojciech Dziworski EU #MWC14 #mHealth
Wojciech Dziworski EU #MWC14 #mHealth3GDR
 
Tackling societal challenges through digital transformation
Tackling societal challenges through digital transformationTackling societal challenges through digital transformation
Tackling societal challenges through digital transformationGames for Health Europe
 
Zilgalvis, Peteris - Sustainability Through Innovative. Partnerships: Global ...
Zilgalvis, Peteris - Sustainability Through Innovative. Partnerships: Global ...Zilgalvis, Peteris - Sustainability Through Innovative. Partnerships: Global ...
Zilgalvis, Peteris - Sustainability Through Innovative. Partnerships: Global ...ponencias_mihealth2012
 
Loukianos Gatzoulis EU #MWC14 #mHealth
Loukianos Gatzoulis EU #MWC14 #mHealthLoukianos Gatzoulis EU #MWC14 #mHealth
Loukianos Gatzoulis EU #MWC14 #mHealth3GDR
 
Workshop 5 - "Feedback from the 15 National Conferences on social aspects"
Workshop 5 - "Feedback from the 15 National Conferences on social aspects"Workshop 5 - "Feedback from the 15 National Conferences on social aspects"
Workshop 5 - "Feedback from the 15 National Conferences on social aspects"EURORDIS - Rare Diseases Europe
 
Eb briefing hiv_strategy
Eb briefing hiv_strategyEb briefing hiv_strategy
Eb briefing hiv_strategyWHO-HIV
 
The Health of the Portuguese. Portugal National Health Plan, Revision and Ext...
The Health of the Portuguese. Portugal National Health Plan, Revision and Ext...The Health of the Portuguese. Portugal National Health Plan, Revision and Ext...
The Health of the Portuguese. Portugal National Health Plan, Revision and Ext...WHO Regional Office for Europe
 
Presentation –Action plan for the health sector response to HIV
Presentation –Action plan for the health sector response to HIV Presentation –Action plan for the health sector response to HIV
Presentation –Action plan for the health sector response to HIV WHO Regional Office for Europe
 
Research funding and research management - FP7 & H2020
Research funding and research management - FP7 & H2020Research funding and research management - FP7 & H2020
Research funding and research management - FP7 & H2020Elena Petelos
 
Curso “La Política de Investigación e Innovación en el marco europeo y nacion...
Curso “La Política de Investigación e Innovación en el marco europeo y nacion...Curso “La Política de Investigación e Innovación en el marco europeo y nacion...
Curso “La Política de Investigación e Innovación en el marco europeo y nacion...EU_CHRODIS
 
Community Based Health Insurance as a Pathway to Universal Health Coverage: L...
Community Based Health Insurance as a Pathway to Universal Health Coverage: L...Community Based Health Insurance as a Pathway to Universal Health Coverage: L...
Community Based Health Insurance as a Pathway to Universal Health Coverage: L...HFG Project
 
Oldham Health Commission
Oldham Health CommissionOldham Health Commission
Oldham Health CommissionNHSOldham
 
Catherine Hartmann Secretary General of the European COPD Coalition
Catherine Hartmann Secretary General of the European COPD CoalitionCatherine Hartmann Secretary General of the European COPD Coalition
Catherine Hartmann Secretary General of the European COPD CoalitionCittadinanzattiva onlus
 
Chronic Illness frameworks and Primary Care Physiotherapy
Chronic Illness frameworks and Primary Care PhysiotherapyChronic Illness frameworks and Primary Care Physiotherapy
Chronic Illness frameworks and Primary Care PhysiotherapyPadraigC
 
Implementing-Value-Based-Healthcare-In-Europe-EIT-Summit-2019
Implementing-Value-Based-Healthcare-In-Europe-EIT-Summit-2019Implementing-Value-Based-Healthcare-In-Europe-EIT-Summit-2019
Implementing-Value-Based-Healthcare-In-Europe-EIT-Summit-2019Massimo Talia
 
#MWC15Health joe killen tunstall
#MWC15Health joe killen tunstall#MWC15Health joe killen tunstall
#MWC15Health joe killen tunstall3GDR
 

Ähnlich wie [Horizon 2020] La participación en las redes (20)

Wojciech Dziworski EU #MWC14 #mHealth
Wojciech Dziworski EU #MWC14 #mHealthWojciech Dziworski EU #MWC14 #mHealth
Wojciech Dziworski EU #MWC14 #mHealth
 
Tackling societal challenges through digital transformation
Tackling societal challenges through digital transformationTackling societal challenges through digital transformation
Tackling societal challenges through digital transformation
 
Zilgalvis, Peteris - Sustainability Through Innovative. Partnerships: Global ...
Zilgalvis, Peteris - Sustainability Through Innovative. Partnerships: Global ...Zilgalvis, Peteris - Sustainability Through Innovative. Partnerships: Global ...
Zilgalvis, Peteris - Sustainability Through Innovative. Partnerships: Global ...
 
Loukianos Gatzoulis EU #MWC14 #mHealth
Loukianos Gatzoulis EU #MWC14 #mHealthLoukianos Gatzoulis EU #MWC14 #mHealth
Loukianos Gatzoulis EU #MWC14 #mHealth
 
Workshop 5 - "Feedback from the 15 National Conferences on social aspects"
Workshop 5 - "Feedback from the 15 National Conferences on social aspects"Workshop 5 - "Feedback from the 15 National Conferences on social aspects"
Workshop 5 - "Feedback from the 15 National Conferences on social aspects"
 
Better health for Europe
Better health for EuropeBetter health for Europe
Better health for Europe
 
Integració de serveis de salut a Europa: Reptes de futur
Integració de serveis de salut a Europa: Reptes de futurIntegració de serveis de salut a Europa: Reptes de futur
Integració de serveis de salut a Europa: Reptes de futur
 
Eb briefing hiv_strategy
Eb briefing hiv_strategyEb briefing hiv_strategy
Eb briefing hiv_strategy
 
The Health of the Portuguese. Portugal National Health Plan, Revision and Ext...
The Health of the Portuguese. Portugal National Health Plan, Revision and Ext...The Health of the Portuguese. Portugal National Health Plan, Revision and Ext...
The Health of the Portuguese. Portugal National Health Plan, Revision and Ext...
 
Panel 2 Patricia Clarke
Panel 2 Patricia ClarkePanel 2 Patricia Clarke
Panel 2 Patricia Clarke
 
Presentation –Action plan for the health sector response to HIV
Presentation –Action plan for the health sector response to HIV Presentation –Action plan for the health sector response to HIV
Presentation –Action plan for the health sector response to HIV
 
Research funding and research management - FP7 & H2020
Research funding and research management - FP7 & H2020Research funding and research management - FP7 & H2020
Research funding and research management - FP7 & H2020
 
Curso “La Política de Investigación e Innovación en el marco europeo y nacion...
Curso “La Política de Investigación e Innovación en el marco europeo y nacion...Curso “La Política de Investigación e Innovación en el marco europeo y nacion...
Curso “La Política de Investigación e Innovación en el marco europeo y nacion...
 
Community Based Health Insurance as a Pathway to Universal Health Coverage: L...
Community Based Health Insurance as a Pathway to Universal Health Coverage: L...Community Based Health Insurance as a Pathway to Universal Health Coverage: L...
Community Based Health Insurance as a Pathway to Universal Health Coverage: L...
 
Rationale for ICF Education
Rationale for ICF EducationRationale for ICF Education
Rationale for ICF Education
 
Oldham Health Commission
Oldham Health CommissionOldham Health Commission
Oldham Health Commission
 
Catherine Hartmann Secretary General of the European COPD Coalition
Catherine Hartmann Secretary General of the European COPD CoalitionCatherine Hartmann Secretary General of the European COPD Coalition
Catherine Hartmann Secretary General of the European COPD Coalition
 
Chronic Illness frameworks and Primary Care Physiotherapy
Chronic Illness frameworks and Primary Care PhysiotherapyChronic Illness frameworks and Primary Care Physiotherapy
Chronic Illness frameworks and Primary Care Physiotherapy
 
Implementing-Value-Based-Healthcare-In-Europe-EIT-Summit-2019
Implementing-Value-Based-Healthcare-In-Europe-EIT-Summit-2019Implementing-Value-Based-Healthcare-In-Europe-EIT-Summit-2019
Implementing-Value-Based-Healthcare-In-Europe-EIT-Summit-2019
 
#MWC15Health joe killen tunstall
#MWC15Health joe killen tunstall#MWC15Health joe killen tunstall
#MWC15Health joe killen tunstall
 

Mehr von Vall d'Hebron Institute of Research (VHIR)

"Neurobiología del parto y vínculo materno-filial: eventos no fisiológicos qu...
"Neurobiología del parto y vínculo materno-filial: eventos no fisiológicos qu..."Neurobiología del parto y vínculo materno-filial: eventos no fisiológicos qu...
"Neurobiología del parto y vínculo materno-filial: eventos no fisiológicos qu...Vall d'Hebron Institute of Research (VHIR)
 
"Nuevas perspectivas médicas para luchar contra las enfermedades asociadas a ...
"Nuevas perspectivas médicas para luchar contra las enfermedades asociadas a ..."Nuevas perspectivas médicas para luchar contra las enfermedades asociadas a ...
"Nuevas perspectivas médicas para luchar contra las enfermedades asociadas a ...Vall d'Hebron Institute of Research (VHIR)
 
Interpretation of sequence variants in the biomedical environment: what shoul...
Interpretation of sequence variants in the biomedical environment: what shoul...Interpretation of sequence variants in the biomedical environment: what shoul...
Interpretation of sequence variants in the biomedical environment: what shoul...Vall d'Hebron Institute of Research (VHIR)
 
Variant calling and how to prioritize somatic mutations and inheritated varia...
Variant calling and how to prioritize somatic mutations and inheritated varia...Variant calling and how to prioritize somatic mutations and inheritated varia...
Variant calling and how to prioritize somatic mutations and inheritated varia...Vall d'Hebron Institute of Research (VHIR)
 
"Cost of illness studies in rare diseases: cystic fibrosis as an example" by ...
"Cost of illness studies in rare diseases: cystic fibrosis as an example" by ..."Cost of illness studies in rare diseases: cystic fibrosis as an example" by ...
"Cost of illness studies in rare diseases: cystic fibrosis as an example" by ...Vall d'Hebron Institute of Research (VHIR)
 
Sr. Juan Carrión: 'Unidos nuestros derechos avanzan: análisis de las 14 propu...
Sr. Juan Carrión: 'Unidos nuestros derechos avanzan: análisis de las 14 propu...Sr. Juan Carrión: 'Unidos nuestros derechos avanzan: análisis de las 14 propu...
Sr. Juan Carrión: 'Unidos nuestros derechos avanzan: análisis de las 14 propu...Vall d'Hebron Institute of Research (VHIR)
 
Dr. Jordi Llinares: Research, regulations and rare deseases. Is there a meeti...
Dr. Jordi Llinares: Research, regulations and rare deseases. Is there a meeti...Dr. Jordi Llinares: Research, regulations and rare deseases. Is there a meeti...
Dr. Jordi Llinares: Research, regulations and rare deseases. Is there a meeti...Vall d'Hebron Institute of Research (VHIR)
 
Ivan Erill: "Beyond the Regulon: reconstructing the SOS response of the human...
Ivan Erill: "Beyond the Regulon: reconstructing the SOS response of the human...Ivan Erill: "Beyond the Regulon: reconstructing the SOS response of the human...
Ivan Erill: "Beyond the Regulon: reconstructing the SOS response of the human...Vall d'Hebron Institute of Research (VHIR)
 
"The role of the nuclear factor TDP 43 in neurodegeneration" by Francisco E. ...
"The role of the nuclear factor TDP 43 in neurodegeneration" by Francisco E. ..."The role of the nuclear factor TDP 43 in neurodegeneration" by Francisco E. ...
"The role of the nuclear factor TDP 43 in neurodegeneration" by Francisco E. ...Vall d'Hebron Institute of Research (VHIR)
 
Registros de enfermedades raras: Sistemas de información básicos para el fome...
Registros de enfermedades raras: Sistemas de información básicos para el fome...Registros de enfermedades raras: Sistemas de información básicos para el fome...
Registros de enfermedades raras: Sistemas de información básicos para el fome...Vall d'Hebron Institute of Research (VHIR)
 
El estudio de la efectividad de las intervenciones enfermeras ¿una cuenta pen...
El estudio de la efectividad de las intervenciones enfermeras ¿una cuenta pen...El estudio de la efectividad de las intervenciones enfermeras ¿una cuenta pen...
El estudio de la efectividad de las intervenciones enfermeras ¿una cuenta pen...Vall d'Hebron Institute of Research (VHIR)
 

Mehr von Vall d'Hebron Institute of Research (VHIR) (20)

Human Cell Line Authentication. Why is it so important?
Human Cell Line Authentication. Why is it so important?Human Cell Line Authentication. Why is it so important?
Human Cell Line Authentication. Why is it so important?
 
"Neurobiología del parto y vínculo materno-filial: eventos no fisiológicos qu...
"Neurobiología del parto y vínculo materno-filial: eventos no fisiológicos qu..."Neurobiología del parto y vínculo materno-filial: eventos no fisiológicos qu...
"Neurobiología del parto y vínculo materno-filial: eventos no fisiológicos qu...
 
"Nuevas perspectivas médicas para luchar contra las enfermedades asociadas a ...
"Nuevas perspectivas médicas para luchar contra las enfermedades asociadas a ..."Nuevas perspectivas médicas para luchar contra las enfermedades asociadas a ...
"Nuevas perspectivas médicas para luchar contra las enfermedades asociadas a ...
 
Interpretation of sequence variants in the biomedical environment: what shoul...
Interpretation of sequence variants in the biomedical environment: what shoul...Interpretation of sequence variants in the biomedical environment: what shoul...
Interpretation of sequence variants in the biomedical environment: what shoul...
 
Variant calling and how to prioritize somatic mutations and inheritated varia...
Variant calling and how to prioritize somatic mutations and inheritated varia...Variant calling and how to prioritize somatic mutations and inheritated varia...
Variant calling and how to prioritize somatic mutations and inheritated varia...
 
Data analysis pipelines for NGS applications
Data analysis pipelines for NGS applicationsData analysis pipelines for NGS applications
Data analysis pipelines for NGS applications
 
NGS and the molecular basis of disease: a practical view
NGS and the molecular basis of disease: a practical viewNGS and the molecular basis of disease: a practical view
NGS and the molecular basis of disease: a practical view
 
Prof. Adolfo García Sastre: Influenza epidemics and pandemics
Prof. Adolfo García Sastre: Influenza epidemics and pandemicsProf. Adolfo García Sastre: Influenza epidemics and pandemics
Prof. Adolfo García Sastre: Influenza epidemics and pandemics
 
Richard horton, barcelona 2014
Richard horton, barcelona 2014Richard horton, barcelona 2014
Richard horton, barcelona 2014
 
"Cost of illness studies in rare diseases: cystic fibrosis as an example" by ...
"Cost of illness studies in rare diseases: cystic fibrosis as an example" by ..."Cost of illness studies in rare diseases: cystic fibrosis as an example" by ...
"Cost of illness studies in rare diseases: cystic fibrosis as an example" by ...
 
Sr. Juan Carrión: 'Unidos nuestros derechos avanzan: análisis de las 14 propu...
Sr. Juan Carrión: 'Unidos nuestros derechos avanzan: análisis de las 14 propu...Sr. Juan Carrión: 'Unidos nuestros derechos avanzan: análisis de las 14 propu...
Sr. Juan Carrión: 'Unidos nuestros derechos avanzan: análisis de las 14 propu...
 
Dr. Tobias Welte: Lessons learned from the CAPNETZ study
Dr. Tobias Welte: Lessons learned from the CAPNETZ studyDr. Tobias Welte: Lessons learned from the CAPNETZ study
Dr. Tobias Welte: Lessons learned from the CAPNETZ study
 
Dr. Jordi Llinares: Research, regulations and rare deseases. Is there a meeti...
Dr. Jordi Llinares: Research, regulations and rare deseases. Is there a meeti...Dr. Jordi Llinares: Research, regulations and rare deseases. Is there a meeti...
Dr. Jordi Llinares: Research, regulations and rare deseases. Is there a meeti...
 
Ivan Erill: "Beyond the Regulon: reconstructing the SOS response of the human...
Ivan Erill: "Beyond the Regulon: reconstructing the SOS response of the human...Ivan Erill: "Beyond the Regulon: reconstructing the SOS response of the human...
Ivan Erill: "Beyond the Regulon: reconstructing the SOS response of the human...
 
"The role of the nuclear factor TDP 43 in neurodegeneration" by Francisco E. ...
"The role of the nuclear factor TDP 43 in neurodegeneration" by Francisco E. ..."The role of the nuclear factor TDP 43 in neurodegeneration" by Francisco E. ...
"The role of the nuclear factor TDP 43 in neurodegeneration" by Francisco E. ...
 
Registros de enfermedades raras: Sistemas de información básicos para el fome...
Registros de enfermedades raras: Sistemas de información básicos para el fome...Registros de enfermedades raras: Sistemas de información básicos para el fome...
Registros de enfermedades raras: Sistemas de información básicos para el fome...
 
Gut microbiota for health: lessons of a metagenomic scan (by Joel Doré)
Gut microbiota for health: lessons of a metagenomic scan (by Joel Doré)Gut microbiota for health: lessons of a metagenomic scan (by Joel Doré)
Gut microbiota for health: lessons of a metagenomic scan (by Joel Doré)
 
TLR ligand functionalized nanocarriers to enhance immunogenicity of vaccines
TLR ligand functionalized nanocarriers to enhance immunogenicity of vaccinesTLR ligand functionalized nanocarriers to enhance immunogenicity of vaccines
TLR ligand functionalized nanocarriers to enhance immunogenicity of vaccines
 
Horizon 2020: Nuevo programa y nuevas reglas
Horizon 2020: Nuevo programa y nuevas reglasHorizon 2020: Nuevo programa y nuevas reglas
Horizon 2020: Nuevo programa y nuevas reglas
 
El estudio de la efectividad de las intervenciones enfermeras ¿una cuenta pen...
El estudio de la efectividad de las intervenciones enfermeras ¿una cuenta pen...El estudio de la efectividad de las intervenciones enfermeras ¿una cuenta pen...
El estudio de la efectividad de las intervenciones enfermeras ¿una cuenta pen...
 

Kürzlich hochgeladen

SGK ĐIỆN GIẬT ĐHYHN RẤT LÀ HAY TUYỆT VỜI.pdf
SGK ĐIỆN GIẬT ĐHYHN        RẤT LÀ HAY TUYỆT VỜI.pdfSGK ĐIỆN GIẬT ĐHYHN        RẤT LÀ HAY TUYỆT VỜI.pdf
SGK ĐIỆN GIẬT ĐHYHN RẤT LÀ HAY TUYỆT VỜI.pdfHongBiThi1
 
How to cure cirrhosis and chronic hepatitis naturally
How to cure cirrhosis and chronic hepatitis naturallyHow to cure cirrhosis and chronic hepatitis naturally
How to cure cirrhosis and chronic hepatitis naturallyZurück zum Ursprung
 
BENIGN BREAST DISEASE
BENIGN BREAST DISEASE BENIGN BREAST DISEASE
BENIGN BREAST DISEASE Mamatha Lakka
 
blood bank management system project report
blood bank management system project reportblood bank management system project report
blood bank management system project reportNARMADAPETROLEUMGAS
 
Role of Soap based and synthetic or syndets bar
Role of  Soap based and synthetic or syndets barRole of  Soap based and synthetic or syndets bar
Role of Soap based and synthetic or syndets barmohitRahangdale
 
ayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologypptayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologypptPradnya Wadekar
 
Bulimia nervosa ( Eating Disorders) Mental Health Nursing.
Bulimia nervosa ( Eating Disorders) Mental Health Nursing.Bulimia nervosa ( Eating Disorders) Mental Health Nursing.
Bulimia nervosa ( Eating Disorders) Mental Health Nursing.aarjukhadka22
 
Mental health Team. Dr Senthil Thirusangu
Mental health Team. Dr Senthil ThirusanguMental health Team. Dr Senthil Thirusangu
Mental health Team. Dr Senthil Thirusangu Medical University
 
historyofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusanguhistoryofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusangu Medical University
 
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptxDNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptxMAsifAhmad
 
Using Data Visualization in Public Health Communications
Using Data Visualization in Public Health CommunicationsUsing Data Visualization in Public Health Communications
Using Data Visualization in Public Health Communicationskatiequigley33
 
Male Infertility, Antioxidants and Beyond
Male Infertility, Antioxidants and BeyondMale Infertility, Antioxidants and Beyond
Male Infertility, Antioxidants and BeyondSujoy Dasgupta
 
MedMatch: Your Health, Our Mission. Pitch deck.
MedMatch: Your Health, Our Mission. Pitch deck.MedMatch: Your Health, Our Mission. Pitch deck.
MedMatch: Your Health, Our Mission. Pitch deck.whalesdesign
 
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptxBreast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptxNaveenkumar267201
 
Basic structure of hair and hair growth cycle.pptx
Basic structure of hair and hair growth cycle.pptxBasic structure of hair and hair growth cycle.pptx
Basic structure of hair and hair growth cycle.pptxkomalt2001
 
pA2 value, Schild plot and pD2 values- applications in pharmacology
pA2 value, Schild plot and pD2 values- applications in pharmacologypA2 value, Schild plot and pD2 values- applications in pharmacology
pA2 value, Schild plot and pD2 values- applications in pharmacologyDeepakDaniel9
 

Kürzlich hochgeladen (20)

GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...
GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...
GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...
 
SGK ĐIỆN GIẬT ĐHYHN RẤT LÀ HAY TUYỆT VỜI.pdf
SGK ĐIỆN GIẬT ĐHYHN        RẤT LÀ HAY TUYỆT VỜI.pdfSGK ĐIỆN GIẬT ĐHYHN        RẤT LÀ HAY TUYỆT VỜI.pdf
SGK ĐIỆN GIẬT ĐHYHN RẤT LÀ HAY TUYỆT VỜI.pdf
 
How to cure cirrhosis and chronic hepatitis naturally
How to cure cirrhosis and chronic hepatitis naturallyHow to cure cirrhosis and chronic hepatitis naturally
How to cure cirrhosis and chronic hepatitis naturally
 
BENIGN BREAST DISEASE
BENIGN BREAST DISEASE BENIGN BREAST DISEASE
BENIGN BREAST DISEASE
 
blood bank management system project report
blood bank management system project reportblood bank management system project report
blood bank management system project report
 
Role of Soap based and synthetic or syndets bar
Role of  Soap based and synthetic or syndets barRole of  Soap based and synthetic or syndets bar
Role of Soap based and synthetic or syndets bar
 
ayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologypptayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologyppt
 
Bulimia nervosa ( Eating Disorders) Mental Health Nursing.
Bulimia nervosa ( Eating Disorders) Mental Health Nursing.Bulimia nervosa ( Eating Disorders) Mental Health Nursing.
Bulimia nervosa ( Eating Disorders) Mental Health Nursing.
 
Mental health Team. Dr Senthil Thirusangu
Mental health Team. Dr Senthil ThirusanguMental health Team. Dr Senthil Thirusangu
Mental health Team. Dr Senthil Thirusangu
 
historyofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusanguhistoryofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusangu
 
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptxDNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
 
Using Data Visualization in Public Health Communications
Using Data Visualization in Public Health CommunicationsUsing Data Visualization in Public Health Communications
Using Data Visualization in Public Health Communications
 
How to master Steroid (glucocorticoids) prescription, different scenarios, ca...
How to master Steroid (glucocorticoids) prescription, different scenarios, ca...How to master Steroid (glucocorticoids) prescription, different scenarios, ca...
How to master Steroid (glucocorticoids) prescription, different scenarios, ca...
 
American College of physicians ACP high value care recommendations in rheumat...
American College of physicians ACP high value care recommendations in rheumat...American College of physicians ACP high value care recommendations in rheumat...
American College of physicians ACP high value care recommendations in rheumat...
 
Male Infertility, Antioxidants and Beyond
Male Infertility, Antioxidants and BeyondMale Infertility, Antioxidants and Beyond
Male Infertility, Antioxidants and Beyond
 
MedMatch: Your Health, Our Mission. Pitch deck.
MedMatch: Your Health, Our Mission. Pitch deck.MedMatch: Your Health, Our Mission. Pitch deck.
MedMatch: Your Health, Our Mission. Pitch deck.
 
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptxBreast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
 
Basic structure of hair and hair growth cycle.pptx
Basic structure of hair and hair growth cycle.pptxBasic structure of hair and hair growth cycle.pptx
Basic structure of hair and hair growth cycle.pptx
 
Immune labs basics part 1 acute phase reactants ESR, CRP Ahmed Yehia Ismaeel,...
Immune labs basics part 1 acute phase reactants ESR, CRP Ahmed Yehia Ismaeel,...Immune labs basics part 1 acute phase reactants ESR, CRP Ahmed Yehia Ismaeel,...
Immune labs basics part 1 acute phase reactants ESR, CRP Ahmed Yehia Ismaeel,...
 
pA2 value, Schild plot and pD2 values- applications in pharmacology
pA2 value, Schild plot and pD2 values- applications in pharmacologypA2 value, Schild plot and pD2 values- applications in pharmacology
pA2 value, Schild plot and pD2 values- applications in pharmacology
 

[Horizon 2020] La participación en las redes

  • 1. La Participación en redes Ejemplo de la EIP AHA Anaïs Le Corvec Unitat de Projectes de Recerca - Vall d’Hebron Institut de Recerca 24 de Octubre 2013
  • 2. Que es la EIP AHA? Porque participar? Que ventajas, y pasos a seguir?
  • 3. Active and Healthy Ageing A European Innovation Partnership
  • 4. OBJECTIVES -addressing societal challenges and, in so doing, -enhancing Europe's competitiveness, against the background of globalisation and current fiscal constraints. The concept provides for a strategic approach to innovation which has its origins in the Europe 2020 strategy. In addressing the challenge of ageing, the European Commission aims to increase by two years the average number of healthy life years (HLYs) in the European Union by 2020 : • improving the health status and quality of life of European citizens, with a particular focus on older people; • supporting the long-term sustainability and efficiency of health and social care systems; and • enhancing the competitiveness of EU industry through an improved business environment providing the foundations for growth
  • 5. LOS GRUPOS DE TRABAJO 1. Prescription and adherence action at the regional level. 2. Personal health management, starting with a falls prevention initiative. 3. Action for prevention of functional decline and frailty. 4. Replicating and tutoring integrated care for chronic diseases, including remote monitoring at regional level 5. Development of interoperable independent living solutions, including guidelines for business models
  • 6. European Innovation Partnership on Active and Healthy Ageing B3: Integrated Care Action Group
  • 7. Why engage in the EIP-AHA? Learn from the others’ good practice Combine evidence Collaboration leading to efficiency in (re-)design and validation of innovative care services Efficiency of design leading to expansion of services to larger population - with the same level of investment Being stronger in application for funding at local/national level Local industry seeing a larger market, beyond the “local border” Political support
  • 8. Challenges to care delivery models Ageing society Health workforce shortage Chronic conditions Financial unsustainability HLY vs LE Health inequalities
  • 9. Action Plan Ado p 6 No ted: vem ber 201 2
  • 10. Our activity areas Organisational Models Change Management Workforce Development, Education and Training Risk Stratification Care Pathways Patient Empowerment  Electronic Care Records / ICT/Teleservices Finance, Funding and Procurement Communication and Dissemination mapping, repositories of good practices, toolkits
  • 11. Care pathways – an example Aligning existing funded activities Mapping best practice implementation in the EU regions Evidence base for integrated care pathways and associated guidelines and processes A repository of implemented chronic care pathways, integrated care pathways for chronic conditions Toolkit for Integrated Care Pathways: Care pathway redesign & implementation plans & replication European standardised methodologies & indicators Standardised protocols, procedures and activity workflows
  • 12. B3 Good Practices • Objective: to gather an initial map of current integrated care activities relating to the B3 Action Areas • Who: All B3 members were invited to complete the B3 Good Practice template • When: March-September 2013
  • 13. Collection of good practices • 85 good practices • 23 regions • 8 action areas … and the collection is still on-going
  • 14. Contributing Regions and Countries* *Size corresponding to number of good practices
  • 15. Themes • • • • • • 50% of the good practices target one or more chronic disease (cardiovascular diseases, COPD, diabetes, etc) Numerous examples of comprehensive regional programmes for chronicity Wide range of issues , incl. insurance, social security, housing, independent living, volunteering, impact on competitiveness Innovation in technologies, delivery of services and organisation Patient-centered Strong focus on implementation
  • 16. Examples Puglia, Italy: Telecardiology programme to support patients affected by cardiovascular diseases both in case of acute events and management of chronic conditions. •- Over 550.000 ECG performed, •- significant reduction of avoidable death, •- 60% underwent appropriate treatment and no hospitalization unless urgent (only 11%) Basque country: Chronicity strategy Risk stratification of patients - the entire population (2.2mio) included - 100% of health professionals know what care approach the patient need in relation to their risks - 11,000 hospital stay reduction & saving of €8.9mio (entire strategy)
  • 17. Role of European Commission Political advocacy Support of scale-up, transferability and replication Facilitating collaboration, communication, and partnerships Monitoring & evaluation framework towards the EIP targets & goals Improving framework conditions Alignment of funding instruments Development of a shared and robust evidence base Enabling the exchange and transfer of good practices
  • 18. EIP MEANS NO FUNDING BUT! NETWORKING (THROUGH THE MARKET PLACE) POSSIBILITY TO INFLUENCE FUTURE FUNDING PROGRAMMES START NEW PROJECTS AND INITIATIVES IN RESEARCH BUT ALSO CLOSE TO MARKET
  • 19. GRACIAS POR SU ATENCIÓN! EQUIPO PROYECTOS DE INVESTIGACIÓN VALL D’HEBRON INSTITUTE OF RESEARCH Cualquier duda: ugp@vhir.org